Estimate staff time, revenue leakage, and payback for PA follow-up automation

What does manual prior authorization follow-up cost a pulmonology practice?

TL;DR: Manual prior authorization follow-up costs a pulmonology practice in three ways: staff hours spent checking portals, reading faxes, and calling payers; revenue lost when biologic, DME, sleep study, and procedure authorizations expire, stall, or get denied without appeal; and patients who abandon or delay care while they wait. The staff-time piece alone can be estimated as follow-up touches per PA × minutes per touch × monthly PA volume × loaded hourly cost. For a mid-sized independent pulmonology group, that number often lands in the hundreds of thousands of dollars a year before revenue leakage is counted.

Why follow-up, not submission, drives prior authorization cost

When practices estimate what prior authorization costs, they usually count submissions. That undercounts badly. Submission is a single event; follow-up repeats until the request resolves, and in pulmonology many requests need several rounds.

Consider what happens after a typical pulmonology PA goes out. Someone confirms the payer received it. Someone checks the portal a few days later. If the payer pends for an eosinophil count or recent spirometry, someone pulls the record and sends it. If the request is a biologic, someone also checks the specialty pharmacy and the manufacturer hub. If it's a CPAP or oxygen order, someone calls the DME supplier. Each of those is a touch, and each touch costs staff time.

The national numbers show the scale. The AMA's physician survey found practices complete 39 prior authorizations per physician per week, physicians and staff spend about 13 hours a week on them, and 40% of physicians have staff who work exclusively on PAs. Turnaround isn't improving much either. A September 2026 MGMA Stat poll found 44% of practice leaders saw slower payer PA turnaround than in 2025, and only 7% saw faster. Slower turnaround means more follow-up touches per request.

How do you calculate the staff cost of manual PA follow-up?

Use a simple model you can fill in with your own data. The formula:

Monthly follow-up cost = monthly PA volume × follow-up touches per PA × minutes per touch ÷ 60 × loaded hourly cost

Here's a worked example for an eight-physician independent pulmonology practice. Every input below is an assumption; replace each one with your own numbers.

  • Monthly PA volume: 8 physicians × 39 PAs per week (the AMA average) × about 4.3 weeks = roughly 1,350 PAs per month.
  • Follow-up touches per PA: 3 (receipt confirmation, one status check, and one response or call). Biologics and DME often need more; simple imaging may need fewer.
  • Minutes per touch: 8, covering portal login and search, fax review, or a short call. Hold times push this higher.
  • Loaded hourly cost: $32, covering wages, benefits, and payroll taxes for a PA coordinator.

Run the math: 1,350 × 3 × 8 = 32,400 minutes, or 540 hours a month. At $32 an hour, that's about $17,300 a month, or roughly $207,000 a year, spent only on follow-up. At around 173 working hours per FTE per month, 540 hours is a little over three full-time positions.

Your numbers will differ. The point is to measure them. Pull a week of PA activity, count the touches, and time a sample of them. Most practices find the touch count is higher than they assumed, especially for biologics.

Where the follow-up hours go in pulmonology

Not every PA costs the same to follow. Break your volume into request types and you'll usually find a small share of requests eating most of the hours.

  • Biologics are the heaviest. Each start involves the payer, a benefit investigation, a specialty pharmacy or manufacturer hub, and often copay assistance, and every one of those can generate its own status check. Reauthorizations add a second cycle six or twelve months later.
  • DME (CPAP, BiPAP, home oxygen) adds a third party. Even when a supplier submits the authorization, your staff fields the calls when it stalls.
  • Sleep studies and imaging often run through benefit managers with separate portals and their own documentation rules.
  • Procedures such as bronchoscopy carry service windows, so follow-up has to continue past approval until the case is scheduled.
  • Routine medications through pharmacy-benefit ePA networks tend to be the lightest.

A useful exercise: tag one month of PAs by type and count touches for each. If biologics are 15% of volume but 40% of follow-up time, that's where process changes or automation will pay back first. It also tells you whether to staff a dedicated biologic coordinator rather than spreading that work across the whole team.

The hidden costs that don't show up on payroll

Staff time is the visible cost. The bigger number for many pulmonology practices is revenue that quietly never arrives.

Expired approvals

Sleep studies, imaging, and procedures are often approved for a fixed service window. If scheduling doesn't know the approval came through, or the patient can't be scheduled in time, the authorization expires and the practice either reschedules with a new PA or performs the service at risk of denial.

Lapsed biologic reauthorizations

Biologic approvals typically run six or twelve months. When a reauth is missed, the specialty pharmacy rejects the refill, the patient misses doses, and the practice spends hours recovering. Some patients don't come back.

Denials that never get appealed

A denial that arrives by fax and sits unread past the appeal deadline becomes a write-off or a lost patient. That's a follow-up failure, not a clinical one.

Patient attrition

Long waits push patients to give up or go elsewhere. For a referral-driven specialty like pulmonology, losing a patient during the PA process also means losing the follow-up visits, testing, and procedures that would have followed.

You can estimate leakage with the same approach as staff time. Count last quarter's expired approvals, missed reauths, and unappealed denials, then multiply each by the average reimbursement for that service. If even five sleep studies a month lapse because nobody scheduled them inside the approval window, multiply five by your average sleep study reimbursement and annualize it.

What changes the math in 2026

Two things are pulling the cost of manual follow-up in different directions this year.

First, federal rules are tightening payer timelines. Under the CMS Interoperability and Prior Authorization final rule, Medicare Advantage, Medicaid, and CHIP plans must decide expedited requests within 72 hours and standard requests within 7 calendar days as of January 1, 2026. Faster decisions from those plans should reduce some status checks.

Second, those timelines raise the cost of slow responses on your side. When a payer pends a request, a faster clock means a shorter window to answer. Practices that check status manually twice a week can miss a pend entirely. And commercial plans aren't bound by the same rule, so your queue now runs at two speeds.

The net effect for most pulmonology groups: fewer long waits on federal-program plans, more pressure to respond quickly, and no relief on commercial payers, benefit managers, or specialty pharmacies.

How to compare manual follow-up against automation

Once you know your baseline, you can compare it against what automation would cost. Prior authorization tools are typically priced per transaction, per provider, per FTE equivalent, or as a platform subscription. Translate any quote into a monthly number and set it next to three baselines:

  1. Staff follow-up cost from the formula above.
  2. Revenue leakage from expired approvals, missed reauths, and unappealed denials.
  3. Hiring avoided, if your PA volume is growing and you'd otherwise add coordinators.

Be honest about what automation won't change. Physicians still do peer-to-peer reviews. Clinicians still decide whether to appeal medical-necessity denials. Some payers will still require phone calls. A realistic projection assumes automation removes a large share of routine checking and record-gathering, not all PA work.

Also count the transition cost: implementation time, EHR integration, and staff time to learn a new workflow. A tool that saves 400 hours a month but takes six months to connect to your EHR has a different payback curve than one that's live in weeks.

Where AI agents reduce follow-up hours

The category with the most direct impact on follow-up cost is AI agents that do the checking themselves. Rather than organizing tasks for staff, they log into portals, read incoming fax determinations, pull requested records from the chart, and write results back to the EHR, routing only exceptions to a human.

Honey Health's Prior Authorization agent works this way. For a pulmonology practice, that means status checks on biologics, DME, sleep studies, and imaging run on schedule without a coordinator logging in, pends get answered with the right spirometry or eosinophil data, and reauth dates surface before they lapse. Your coordinators shift from chasing status to handling peer-to-peers, appeals, and patient questions.

Run the pilot math before committing. Pick one or two high-volume payers, measure touches per PA and days to decision for 30 days before and after, and compare the cost per resolved PA. That gives your partners or board a number rooted in your own operations rather than a vendor's case study.

Frequently Asked Questions

How much staff time does prior authorization take in a pulmonology practice?

Nationally, the AMA reports practices complete about 39 PAs per physician per week and spend roughly 13 hours a week on them. Pulmonology often runs higher because biologics, DME, and sleep studies need extra follow-up. Measure your own touches per PA for the most accurate picture.

What is a reasonable loaded hourly cost for a PA coordinator?

It depends on your market, but include wages, benefits, and payroll taxes, not just the hourly wage. Many practices use a loaded rate meaningfully above base pay. Use your own payroll data rather than a national average when building the business case.

How do I measure revenue lost to prior authorization problems?

Count expired approvals, missed biologic reauthorizations, denials not appealed before the deadline, and patients who left during the PA process over the last quarter. Multiply each by the average reimbursement for that service, then annualize. Even rough counts usually reveal a meaningful number.

Does the 2026 CMS prior authorization rule reduce follow-up costs?

Partly. Medicare Advantage, Medicaid, and CHIP plans must now decide within 72 hours or 7 calendar days, which reduces long waits for those plans. Commercial payers, benefit managers, and specialty pharmacies aren't covered, and faster payer clocks shorten your window to respond to pends.

Which pulmonology prior authorizations cost the most to follow up?

Biologics usually cost the most because each case involves the payer, a specialty pharmacy or hub, copay programs, and recurring reauthorizations. DME and sleep studies follow, since they add suppliers and benefit managers. Tag a month of PAs by type and count touches to confirm the pattern in your practice.

How long does it take for PA automation to pay for itself?

It depends on your volume, current staffing, implementation time, and pricing. Practices with high biologic and DME volume and dedicated PA staff tend to see the fastest payback. Run a 30-day pilot and compare cost per resolved PA before and after to get a reliable estimate.

More of our Article
CLINIC TYPE
LOCATION
INTEGRATIONS
More of our Article and Stories